EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Therapeutic effects of extracellular vesicles derived from mesenchymal stem cells primed with disease-conditioned-immune cells in systemic lupus erythematosus

Eun Wha Choi, Il Seob Shin, I-Rang Lim, Jihye Lee, Bongkum Choi, Sungjoo Kim

Arthritis Research & Therapy · 2024

DOI: 10.1186/s13075-024-03435-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis Research & Therapy, 2024. Verfasst von Eun Wha Choi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Clinical Pathology, College of Veterinary Medicine & Institute of Veterinary Science, Kangwon National University, 1 Kangwon…. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Mesenchymal Stem Cells, Extracellular Vesicles, Mice, Inbred NZB. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Systemic lupus erythematosus (SLE) is an incurable chronic autoimmune disease of unknown etiology. Therefore, the development of new treatments is urgently needed. This study aimed to investigate the therapeutic effects of extracellular vesicles (EV) derived from immortalized mesenchymal stem cells (iMSCs) primed with conditioned media obtained from disease-conditioned immune cells (CM-EV) and iMSC-derived EV (ASC-EV) in a murine model of SLE.

Methods

Female NZB/W F1 mice were divided into the control (C, n = 15), ASC-EV (E, n = 15), and CM-EV (CM, n = 15) groups. Mice in the C, E, and CM groups were intravenously administered saline, ASC-EV, and CM-EV, respectively, once weekly from 6 to 42 weeks of age.

Results

Compared to the ASC-EV, the CM-EV showed a significant increase in TGF-β1 production and miR-155-5p and miR-142-3p expression. CM-EV treatment increased survival, decreased anti-dsDNA antibody levels, and ameliorated renal histopathology. Although ASC-EV treatment significantly reduced the incidence of severe proteinuria and improved renal histopathology, it did not significantly improve survival rate. ASC-EV or CM-EV treatment significantly decreased the proportion of pro-inflammatory macrophages (CD11c + CD206-; M1) and M1:M2 ratio. Additionally, CM-EV treatment significantly increased the expression of anti-inflammatory macrophages (CD11c-CD206 + ; M2). Moreover, CM-EV treatment significantly decreased the expression of lupus-specific miRNAs (miR-182-5p and miR-183-5p) in the spleen.

Conclusions

EV derived from iMSCs primed with conditioned media obtained from disease-conditioned immune cells exert immunomodulatory effects and ameliorate SLE in a murine model.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicMesenchymal Stem CellsExtracellular VesiclesMice, Inbred NZBAnimalsFemaleMiceMicroRNAsCulture Media, ConditionedDisease Models, AnimalMesenchymal Stem Cell TransplantationAntibodies, Antinuclear

Stichwörter der Autor:innen

Autoimmune diseasesConditioned mediaExtracellular vesiclesMesenchymal stem cellSystemic lupus erythematosus

Substanzen

MicroRNAsCulture Media, ConditionedMirn155 microRNA, mouseAntibodies, Antinuclear

Autor:innen und Institutionen

  • Department of Veterinary Clinical Pathology, College of Veterinary Medicine & Institute of Veterinary Science, Kangwon National University, 1 Kangwondaehak-gil, Chuncheon, Gangwon-do, 24341, Republic of Korea. ewchoi@ka…
  • Department of Veterinary Clinical Pathology, College of Veterinary Medicine & Institute of Veterinary Science, Kangwon National University, 1 Kangwondaehak-gil, Chuncheon, Gangwon-do, 24341, Republic of Korea.
  • Bioanalysis Center, GenNBio Inc, 700, Daewangpangyo-ro, Bundang-gu, Seongnam-Si, Gyeonggi-do, 13488, Republic of Korea.
  • GenNBio Inc, 80, Deurimsandan 2-ro, Cheongbuk-eup, Pyeongtaek-si, Gyeonggi-do, 17796, Republic of Korea.
  • Current address: Department of Surgery, Cheju Halla General Hospital, 65, Doryeong-ro, Jeju-Si, Jeju-do, 63127, Republic of Korea.

Zitieren

APA

Choi, E. W., Shin, I. S., Lim, I. R., Lee, J., Choi, B., & Kim, S. (2024). Therapeutic effects of extracellular vesicles derived from mesenchymal stem cells primed with disease-conditioned-immune cells in systemic lupus erythematosus. Arthritis Research & Therapy. https://doi.org/10.1186/s13075-024-03435-1

Vancouver

Choi EW, Shin IS, Lim IR, Lee J, Choi B, Kim S. Therapeutic effects of extracellular vesicles derived from mesenchymal stem cells primed with disease-conditioned-immune cells in systemic lupus erythematosus. Arthritis Research & Therapy. 2024. doi:10.1186/s13075-024-03435-1

BibTeX
@article{Choi2024,
  author = {Choi, Eun Wha and Shin, Il Seob and Lim, I-Rang and Lee, Jihye and Choi, Bongkum and Kim, Sungjoo},
  title = {Therapeutic effects of extracellular vesicles derived from mesenchymal stem cells primed with disease-conditioned-immune cells in systemic lupus erythematosus},
  journal = {Arthritis Research & Therapy},
  year = {2024},
  doi = {10.1186/s13075-024-03435-1}
}
Kostenlos starten →